Zusammenfassung
Etwa ein Prozent der Patienten in unserem allgemeinchirurgischen Krankengut weist eine terminale Niereninsuffizienz auf Diese führt zu pathophysiologischen Veränderungen, die die Pharmakokinetik und -dynamik der Muskelrelaxanzien beeinflussen können
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agoston, Bowman, Miller, Viby-Mogensen. Clinical experiences with norcuron. Symposium Geneve 21–22 April 1983, Excerpta Medica, Current Clinical Practice, Series 11
Bach A, Layer M (1990) Muskelrelaxanzien zur Nierentransplantation: Ein Vergleich zwischen Vecuronium und Atracurium. Anaesthesist 39: 96–100
Bencini AF et al. (1986) Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 65: 245
Bevan DR et al. (1984) Vecuronium in renal failure. Can Anaesth Soc J 31: 491-
Berntman L et al. (1989) Atracurium and pancuronium in renal insufficiency. Acta Anaesthesiol Scand 33: 48–52
DeBros FM et al. (1986) Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patients. Anesth Analg 65: 743–746
Buzello W, Agoston S (1978) Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium, and pancuronium in patients with normal and impaired renal function. Anaesthesist 27: 319–321
Chappie DJ et al. (1985) Neurological effects of laudanosine in conscious and anaesthetised dogs. Anesthesiology 63: A311
Cronnelly R et al. (1979) Renal function and the pharmacokinetics of neostigmine in anesthetized patients. Anesthesiology 51: 222
Cronnelly R et al. (1980) Pyridostigmine kinetics with and without renal function. Clin Pharmacol Ther 28: 78
Fahey MR et al. (1981) Pharmacokinetics of ORG NC 45 (Norcuron) in patients with and without renal failure. Br J Anaesth 53: 1049
Fahey MR et al. (1985) Effects of renal failure on laudanosine excretion in man. Br J Anaesth 57: 1049
Griffiths RB et al. (1986) Atracurium infusions in patients with renal failure on an ITU. Anaesthesia 41: 375–381
Gramstad L (1987) Atracurium, vecuronium, and pancuronium in end-stage renal failure. Br J Anaesth 59: 995–1003
Gramstad L, Lilleaasen P (1985) Neuromuscular blocking effects of atracurium, vecuronium, and pancuronium during bolus and infusion administration. Br J Anaesth 57: 1052
Hackl W et al. (1988) Protrahierte Vecuroniumwirkung bei einem Patienten mit dialysepflichtiger chronischer Niereninsuffizienz. Anaesthesist 37: 598–600
Hunter JM et al. (1984) Comparison of vecuronium, atracurium, and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth 56: 941
Korde M, Waud BE (1972) Serum potassium concentrations after succinylcholine in patients with renal failure. Anesthesiology 36: 142
Lepage JY et al. (1987) Vecuronium and atracurium in patients with end-stage renal failure. Br J Anaesth 59: 1004–1010
McLeod K et al. (1976) Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Br J Anaesth 48: 341
Miller RD (1986) Pharmacokinetics of atracurium and other nondepolarizing neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction. Br J Anaesth 58: 11S-13S
Miller RD et al. (1972) Succinylcholine induced hyperkalemia in patients with renal failure? Anesthesiology 36: 138
Parker CJR et al. (1988) Disposition of infusions of atracurium and its metabolite, laudanosine, in patients with renal failure and respiratory failure in an ITU. Br J Anaesth 61: 531–540
Powell JN, Golby M (1971) The pattern of potassium liberation following a single dose of suxamethonium in normal and uraemic rats. Br J Anaesth 43: 662
Powell R, Miller RD (1976) The effect of repeated doses of succinylcholine on serum potassium in patients with renal failure. Anesth Analg 54: 746
Scheepstra GL et al. (1986) Convulsive effects and pharmacokinetics of laudanosine in the rat. Euro J Anaesth 3: 371–383
Stenlake JB et al. (1983) Atracurium: conception and inception. Br J Anaesth 55: 3S-10S
Stenlake JB et al. (1984) Biodegradable neuromuscular blocking agents: Stereochemical studies on atracurium and related polyalkylene di-esters. Euro J Med Chem 19: 441–450
Vandenbrom RHG et al. (1990) Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokinet 19(3): 230–240
Walton JD, Farman JV (1973) Suxamethonium, potassium and renal failure. Anaesthesia 28: 626
Ward S, Weatherly BC (1986) Pharmacokinetics of atracurium and its metabolites. Br J Anaesth 58(Suppl 1): 6S
Ward S et al. (1987) Pharmacokinetics of atracurium and its metabolites in patients with normal renal function and in patients in renal failure. Br J Anaesth 59: 697–706
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Loer, S. (1994). Muskelrelaxanzien und terminale Niereninsuffizienz. In: Kirchner, E., Seitz, W. (eds) Klinik der Muskelrelaxation. Steinkopff. https://doi.org/10.1007/978-3-642-95977-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-95977-6_8
Publisher Name: Steinkopff
Print ISBN: 978-3-642-95978-3
Online ISBN: 978-3-642-95977-6
eBook Packages: Springer Book Archive